Related Experiment Videos
Phenotypic variability of aprataxin gene mutations
C Tranchant1, M Fleury, M C Moreira
1Clinique neurologique, Hôpitaux universitaires, CNRS, INSERM, Strasbourg. France. Christine.Tranchant@chru-strasbourg.fr
Neurology
|March 12, 2003
Summary
This study details three non-Portuguese, non-Japanese patients with aprataxin gene mutations, revealing varied clinical presentations and genetic findings. It highlights the W279X mutation
Area of Science:
- Genetics
- Neurology
- Molecular Biology
Background:
- Aprataxin gene mutations are associated with ataxia with ocular motor apraxia (OMA).
- The W279X mutation is linked to a Portuguese founding haplotype.
- Clinical manifestations can vary, even with the same mutation.
Observation:
- Three patients from Italy and France with aprataxin gene mutations were analyzed.
- Patient 1, from Italy, presented with typical ataxia and OMA, homozygous for W279X.
- Patients 2 and 3, French siblings, lacked OMA and hypoalbuminemia, exhibiting compound heterozygosity for W279X and K197Q.
Findings:
- The W279X mutation, previously linked to a specific haplotype, was found in an Italian patient with classic symptoms.
- French siblings carrying the W279X mutation alongside a novel K197Q mutation showed different clinical features, lacking OMA and hypoalbuminemia.
- This suggests that genetic background and mutation combinations influence the phenotype of aprataxin-related disorders.
Implications:
- Expanding the known spectrum of aprataxin mutations and their associated clinical phenotypes.
- Understanding genotype-phenotype correlations in rare genetic neurological disorders.
- Informing genetic counseling and potential therapeutic strategies for patients with aprataxin gene mutations.